CHARLES CIOLINO: Open Payments
NPI 1841393121 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,001 in 83 payments from 10 companies in 2025. Trend: 2023 $1,283 · 2024 $1,667 · 2025 $2,001
Food & beverage: $1,890Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $376 |
| Axsome Therapeutics, Inc. | 9 | $339 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $324 |
| Teva Pharmaceuticals USA, Inc. | 7 | $293 |
| Vanda Pharmaceuticals Inc. | 11 | $272 |
| E.R. Squibb & Sons, L.L.C. | 4 | $160 |
| Almatica Pharma LLC | 7 | $124 |
| Neurocrine BioSciences, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Bausch Health US, LLC | 1 | $16 |
Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, AUSTEDO XR, COBENFY, LOREEV XR, INGREZZA.
Industry payments across NJ — which companies pay providers there.
